National Institutes of Health · Department of Health and Human Services
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Key facts
- Deadline
- Due Nov 2, 2026 · 27 days left
- Award size
- Not specified — see notice
- Cost share / match
- Not required
- Who can apply
- County government, Other (see eligibility), Nonprofit with 501(c)(3), Private college or university, City or town government, Public college or university, Tribal government, Special district (utility, fire, etc.), Nonprofit without 501(c)(3), Larger business, Tribal organization, Small business, School district, State government
- Where
- Anywhere in the U.S., including Tennessee
Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. The deadline is in 27 days. If your registration isn't already active, it may not be ready in time, so check it today. Grant-ready checklist
How this fits you
- Available in Tennessee (nationwide program)
- No cost share required
- Tennessee recipients since 2023: 24
Tell us who you are to see whether you're eligible.
Read the official notice View on Grants.gov Add deadline to my calendar
About this grant
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review].
The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Eligibility (from the notice)
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Who in Tennessee has won this program
24 awards to Tennessee recipients in 4 counties since federal FY2023. Largest shown:
| Recipient | Where | Amount | FY |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville, Davidson County | $6.7M | 2011 |
| St Jude Children'S Research Hospital Inc | Memphis, Shelby County | $5.8M | 2008 |
| Vanderbilt University | Nashville, Davidson County | $4.3M | 2010 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $3.9M | 2012 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $3.3M | 2018 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $3.2M | 2026 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $2.7M | 2020 |
| Vanderbilt University | Nashville, Davidson County | $2.6M | 2022 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $2M | 2022 |
| University Of Tennessee | Memphis, Shelby County | $1.7M | 2016 |
| University Of Tennessee | Memphis, Shelby County | $1.6M | 2018 |
| Vanderbilt University | Nashville, Davidson County | $1.6M | 2024 |
Source: USAspending.gov. Past awards show who this program funds; they don't guarantee future awards.
About the program (93.846)
Arthritis, Musculoskeletal and Skin Diseases Research — NIAMS
How applications are judged
The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...
Matching requirements
This program has no statutory formula.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Examples of funded projects
Not Applicable.